Rankings
▼
Calendar
LQDA FY 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena
LQDA
Liquidia Corporation
$3B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
-20.0% YoY
Gross Profit
$8M
58.0% margin
Operating Income
-$121M
-866.6% margin
Net Income
-$130M
-931.7% margin
EPS (Diluted)
$-1.66
Cash Flow
Operating Cash Flow
-$93M
Free Cash Flow
-$98M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$230M
Total Liabilities
$153M
Stockholders' Equity
$77M
Cash & Equivalents
$176M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$17M
-20.0%
Gross Profit
$8M
$15M
-44.4%
Operating Income
-$121M
-$73M
-65.3%
Net Income
-$130M
-$79M
-66.1%
← Q4 2023
All Quarters
Q1 2024 →